VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | Pediatric MS: where does research need to move?

Tanuja Chitnis • 24 May 2020
EAN 2020
Multiple Sclerosis and Related Disorders
TERIKIDS Treatment Trial Updates

Tanuja Chitnis, MD, FAAN, Massachusetts General Hospital, Boston, MA, discusses the current unmet needs in pediatric multiple sclerosis (MS). This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Tanuja Chitnis

1:38
Changing approaches to cognitive assessment in MS
Tanuja Chitnis • 23 Feb 2021
1:45
MS disease stage modulates the relationship between serum neurofilament light and age
Tanuja Chitnis • 23 Feb 2021
1:34
Serum neurofilament levels are associated with health outcomes and resource use in MS
Tanuja Chitnis • 23 Feb 2021
2:12
TERIKIDS study: teriflunomide in pediatric patients with relapsing MS
Tanuja Chitnis • 24 May 2020

Related Videos

4:26
Decoding the genetic predisposition to PML in patients on natalizumab
Eli Hatchwell • 24 Oct 2023
1:50
A PML risk genetic test to identify at-risk patients on natalizumab
Eli Hatchwell • 24 Oct 2023
8:18
Advancements in PML genetic risk assessment
Eli Hatchwell • 24 Oct 2023
2:38
Influence of metabolites on inflammation and dietary implications
André Ortlieb Guerreiro Cacais • 23 Oct 2023
The content of VJNeurology is intended for healthcare professionals